Arabic Arabic English English French French German German
dark

Medtronic’s Emprint catheter kit receives FDA Breakthrough designation

Medtronic has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for the Emprint ablation catheter kit – an investigational device not yet approved or cleared in the United States. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

3D Systems launches new addition to VSP surgical portfolio

Next Post

Novartis signs initial agreement to reserve capacity and implement the technology transfer for the production of the active pharmaceutical ingredient for Roche’s Actemra/RoActemra®

Related Posts
Total
0
Share